NEW YORK--(BUSINESS WIRE)--Jan. 3, 2006--Amphion Innovations PLC (AMP.L), the developer of technology and life sciences businesses, today announces that it has completed additional investments in its existing portfolio companies amounting to $2.23 million. An additional $500,000 has been invested in Motif Biosciences Inc. (“Motif”) as part of an ongoing Series B financing. Motif is a population genetics company working to identify the genetic causes of major diseases by working with a unique, rich, and defensible source of human genetic data from the Persian Gulf states.
